<DOC>
	<DOCNO>NCT00004114</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop cancer cell divide stop grow die . Peripheral stem cell transplantation may able replace immune cell destroy chemotherapy use kill cancer cell . PURPOSE : Phase I trial study effectiveness chemotherapy plus peripheral stem cell transplantation treat patient advanced hematologic cancer .</brief_summary>
	<brief_title>Chemotherapy Plus Peripheral Stem Cell Transplantation Treating Patients With Advanced Hematologic Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine feasibility allogeneic engraftment unrelated match allogeneic peripheral blood stem cell transplantation precede nonmyeloablative , fludarabine base condition regimen patient advance hematologic malignancy . II . Determine toxicity regimen , especially graft versus host disease , patient . OUTLINE : Patients receive fludarabine IV 30-60 minute day -7 -4 , cyclophosphamide IV 30 minute day -7 -5 , cytarabine IV 2 hour day -4 -3 . Allogeneic peripheral blood stem cell infuse day 0 . Filgrastim ( G-CSF ) administer IV 1 hour subcutaneously begin day 1 continue blood count recover . Patients follow weekly day 60 monthly 10 month . PROJECTED ACCRUAL : A total 6 patient accrue study .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven advanced hematologic malignancy unsuitable standard allogeneic bone marrow transplantation One follow type : Refractory relapse acute myelogenous lymphocytic leukemia Over 55 year Chronic myelogenous leukemia fail interferon treatment Over 55 year Lymphoma , chronic lymphocytic leukemia , Hodgkin 's disease , multiple myeloma : Refractory OR More 2 relapse OR Relapse autologous peripheral blood stem cell transplantation Myelodysplastic syndrome refractory anemia Severe aplastic anemia Under 55 year either organ dysfunction eligible standard allogeneic bone marrow transplant due one following : Chronic hepatitis LVEF le 50 % Karnofsky le 70 % Unrelated match donor available PATIENT CHARACTERISTICS : Age : See Disease Characteristics Adult Performance status : See Disease Characteristics Karnofsky 60100 % Life expectancy : Not specify Hematopoietic : Not specify Hepatic : See Disease Characteristics SGOT/SGPT great 4 time upper limit normal Renal : Creatinine great 2 mg/dL Cardiovascular : See Disease Characteristics Pulmonary : DLCO least 50 % predict Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : See Disease Characteristics Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>recurrent adult Hodgkin lymphoma</keyword>
	<keyword>recurrent cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>recurrent adult acute myeloid leukemia</keyword>
	<keyword>recurrent adult acute lymphoblastic leukemia</keyword>
	<keyword>relapse chronic myelogenous leukemia</keyword>
	<keyword>refractory chronic lymphocytic leukemia</keyword>
	<keyword>chronic myelomonocytic leukemia</keyword>
	<keyword>recurrent grade 1 follicular lymphoma</keyword>
	<keyword>recurrent grade 2 follicular lymphoma</keyword>
	<keyword>recurrent grade 3 follicular lymphoma</keyword>
	<keyword>recurrent adult diffuse small cleave cell lymphoma</keyword>
	<keyword>recurrent adult diffuse mixed cell lymphoma</keyword>
	<keyword>recurrent adult diffuse large cell lymphoma</keyword>
	<keyword>recurrent adult immunoblastic large cell lymphoma</keyword>
	<keyword>recurrent adult lymphoblastic lymphoma</keyword>
	<keyword>recurrent adult Burkitt lymphoma</keyword>
	<keyword>recurrent adult T-cell leukemia/lymphoma</keyword>
	<keyword>previously treat myelodysplastic syndrome</keyword>
	<keyword>AIDS-related peripheral/systemic lymphoma</keyword>
	<keyword>recurrent mantle cell lymphoma</keyword>
	<keyword>anaplastic large cell lymphoma</keyword>
	<keyword>refractory cytopenia multilineage dysplasia</keyword>
	<keyword>recurrent mycosis fungoides/Sezary syndrome</keyword>
	<keyword>recurrent marginal zone lymphoma</keyword>
	<keyword>recurrent small lymphocytic lymphoma</keyword>
	<keyword>extranodal marginal zone B-cell lymphoma mucosa-associated lymphoid tissue</keyword>
	<keyword>nodal marginal zone B-cell lymphoma</keyword>
	<keyword>splenic marginal zone lymphoma</keyword>
</DOC>